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Background: Pseudomonas aeruginosa are normal flora in the human gastrointestinal 
(GI) tract, which on occasion cause GI tract infection.
Methods: We evaluated the clinical significance of a pure growth of P. aeruginosa in 
fecal specimens in previously healthy children. The records of 45 previously healthy 
children under 15 years of age who were seen between June 2000 and August 2006 and 
who had a pure growth of P. aeruginosa in the stool were retrospectively reviewed.
Results: Of the 45 children, 28 (62%) were infants, three of whom developed sepsis 
secondary to the pseudomonal infection; two of which died. Complications in another 
four included colonic perforation (in two), necrotizing enterocolitis (in one), and 
an anal ulcer resulting in anal stricture (in one). The seven children with compli-
cations were all infants. Although not all children in our study had complete data 
in laboratory determinations, the presence of bandemia, elevated C-reactive protein 
(CRP), anemia and hypoalbuminemia may be of clinical importance.
Conclusion: P. aeruginosa growing in the stool of otherwise healthy children may 
indicate actual infection by the organism and may be associated with severe or 
even fatal disease, particularly in infants. Bandemia, elevated CRP, anemia, and 
hypoalbuminemia give further warning in these patients.
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Infection with Pseudomonas aeruginosa is often con-
sidered to be hospital-acquired, mainly in patients 
with underlying illnesses.1−3 The organism can, how-
ever, cause morbidity and mortality, even in previ-
ously healthy children or adults.4−7 Many reports 
have discussed the seriousness of sepsis, pneumonia 
or urinary tract infection with P. aeruginosa.1,4,8−10 
Because P. aeruginosa are part of the normal human 
gastrointestinal (GI) tract flora, most laboratories 
do not report it in stool culture even with a pure or 
predominant growth; it is not generally considered 
a pathologic finding.11 We designed this study to 
evaluate the clinical significance of a pure growth 
of P. aeruginosa in fecal specimens from previously 
healthy children.
2. Materials and Methods
We retrospectively reviewed the medical records 
of previously healthy children < 15 years old seen 
at Taipei Mackay Memorial Hospital from June 2000 
to August 2006 whose stool cultures yielded a pure 
growth of P. aeruginosa. “Pure growth of P. aerugi-
nosa” was defined as the presence of no other patho-
genic bacteria or colonic normal flora in a blood agar 
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plate with aerobic culture except P. aeruginosa in 5 
days. Children were considered previously healthy 
if they had no known underlying chronic medical 
problems or current medications. There were 49 pa-
tients whose stool had pure growth of P. aeruginosa. 
In the 49 cases, four were excluded because of other 
serious illness (leukemia, aplastic anemia, third-
degree burns), leaving 45 children (27 boys, 18 girls) 
whose records were included in the study. The ages 
ranged from 21 days to 6.5 years (mean 15.1 months, 
median 10.0 months). Data obtained from the med-
ical records included symptoms and signs, laboratory 
data, antibiotics given prior to stool specimen collec-
tion, complications, and outcome. Characteristics 
were compared between patients with and with-
out complications attributable to pseudomonal 
infection. We used chi-square or Fisher’s exact tests 
to compare categorical variables in the two groups. 
Statistical significance was accepted at a p value 
of < 0.05.
3. Results
Reviewing the chart, all the 45 patients had GI symp-
toms such as diarrhea or abdominal distension, and 
stool cultures were done. Of the 45 patients, 28 (62%) 
were infants. Twenty (44%) were initially admitted 
for problems other than GI disease, which included 
pneumonia, acute otitis media and pyuria. Seventeen 
(38%) were given antibiotics, cephalosporin in 13, 
ampicillin in two, macrolide in one and ampicillin 
plus gentamicin in one, before stool specimens were 
collected. Among 36 hospitalized cases, stool cultures 
were performed on the first hospitalized day in 26 
children. The others had an average of 5.1 days (range, 
2−10 days) from admission to take stool specimen 
for culture. Nine children (20%) were treat ed as 
out patients. Stool rotavirus antigens were checked 
in 27 patients, and positive in three cases. Symptoms 
and signs are listed in Table 1, and the complications 
that occurred in seven patients in Table 2. Colonic 
per foration occurred in two children on the 5th day 
and 6th day, respectively, after initial presentation. 
Two patients (4%) with sepsis died, and one patient 
got anal ulcer deep to muscle layer resulting in stric-
ture managed with anal dilatation for 3 months 
(Table 2). Otherwise most children had good prog-
nosis during 6 months’ follow-up. All seven children 
with complications were less than 1 year old, and 
there was statistical significance compared with 
children without complications (chi–square test, 
p = 0.001).
In our study, infants seemed to experience more 
complications when their stool had grown P. aeru-
ginosa. There was also no significant difference 
for the age distribution in infants with or without 
complications. All infants with complications had 
Table 1 Symptoms and signs of 45 children with Pseudomonas enterocolitis
Symptoms/signs Total (n = 45) Complications (n = 7) No complications (n = 38) p value*
Fever  24 (53%) 6 (86%) 18 (47%)
  ≤ 3 d 8 2 6 0.720
  > 3 d 16 4 12
  Mean, range 4.79, 1−12 5.20, 2−9 4.68, 1−12
Diarrhea &  43 (96%) 5 (71%) 38 (100%)
  Bloody stool 3 1 2 0.292
  Mucoid stool 4 1 3 0.472
  Greenish stool 5 0 5 0.352
Vomiting  15 (33%) 0 (0%) 15 (39%) 0.063
Abdominal distension  17 (38%) 5 (71%) 12 (32%) 0.013
Dyspnea 4 (9%) 3 (43%) 1 (3%) < 0.001
Skin lesion 1 (2%) 1 (14%) 0 (0%) 0.010
Poor activity 18 (40%) 6 (86%) 12 (32%) 0.001
Poor appetite 23 (51%) 6 (86%) 17 (45%) 0.010
Tachycardia 5 (11%) 3 (43%) 2 (5%) 0.001
Shock  5 (11%) 4 (57%) 1 (3%) 0.001
Lethargy  4 (9%) 3 (43%) 1 (3%) < 0.001
*Comparison between those with and without complications.
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some abnormality change in white blood count: two 
had neutropenia (absolute neutrophil count < 500/
mm3), the other five had elevated band count (band 
> 300/mm3). We also compared the blood test re-
sults only for the infants with and without compli-
cations. The incidence of bandemia (band form > 10% 
WBC) and anemia (hemoglobin ≤ 10 g/dL) was higher 
(p = 0.010 and 0.001) in infants with complications 
(Table 3). However, there seemed to be no signifi-
cant difference between infants with or without 
complications in the serum C-reactive protein (CRP) 
level (p = 0.070) and neutropenia (p = 0.238).
By the culture reports, no antibiotic-resistant 
strain was noted. Six patients, all with complications, 
were treated with aminoglycosides and anti-
pseudomonal beta-lactam antibiotics. At least 2 
weeks of antibiotics were given, except for the mor-
tality cases. The other one in the complication group, 
who got necrotizing enterocolitis stage I, was treated 
with ampicillin plus gentamicin for 1 week. Among 
the non-complication patients (n = 38), 8 were treated 
with antibiotics (ampicillin plus gentamicin and ana-
erobic antibiotics in 4, ampicillin only in 3 and ceftri-
axone only in 1).
Antibiotics had been given to 17 of the 45 children 
(38%) before a stool specimen was obtained, but we 
did not find significant difference in mortality or 
morbidity whether antibiotics were used or not.
Table 2 Seven patients with complications from Pseudomonas enterocolitis
Gender/age Clinical presentation Complication and outcome
Male/10 mo Fever, diarrhea, shock Anal ulcer deep to muscle layer resulting in stricture;
   managed with anal dilatation
Male/7 mo Fever, diarrhea, abdominal distension Descending colon perforation; recovered
Female/11 mo Fever, abdominal distension 3 colon perforations (including 1 large perforation in
   the cecum); recovered
Female/1 mo Bloody stool Necrotizing enterocolitis stage I; recovered
Male/4 mo Fever, diarrhea, shock  Sepsis*; died
Male/3 mo Fever, diarrhea, vesicle and swelling on Sepsis†; died
  right forearm, shock
Female/6 mo Fever, diarrhea, shock Sepsis‡; recovered
*Urine and cerebrospinal fluid culture: no growth; †urine, wound pus and CSF culture: growth with P. aeruginosa; ‡no other sterile 
site culture was done. mo = months.
Table 3 Laboratory data in infants with Pseudomonas enterocolitis
Lab Total*  Complication No complication p value
WBC (mean) (/mm3) (n = 26) 14,514 11,179
 ANC < 500  4 2 (29%)  2 (11%) 0.238
 Band > 10%  3 3 (43%) 0 (0%) 0.010
Hemoglobin (mean) (g/dL) (n = 26) 10.5 10.8
 ≤ 10  9 6 (86%)  3 (16%) 0.001
 > 10 17 1 (14%) 16 (84%)
Platelet (mean) (/mm3) (n = 26) 150.5 366.1
 ≤ 150,000  4 2 (29%)  2 (11%) NS
 > 150,000 22 5 (71%) 17 (89%)
CRP (mean) (mg/dL) (n = 21) 12.5 8.2
 < 1  9 0 (0%)  9 (69%) 0.070
 1−15  7 4 (57%)  4 (21%)
 > 15  5 3 (43%) 1 (5%)
Albumin (mean) (g/dL) (n = 7) 1.9 2.4
 ≤ 2.5  5 4 (80%)  1 (50%) 0.010
 > 2.5  2 1 (20%)  1 (50%)
*The number of patients for whom a particular laboratory result was available is indicated next to each test item. NS = not 
significant; ANC = absolute neutrophil count; CRP = C-reactive protein.
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4. Discussion
Our study confirms that, even in healthy children, 
P. aeruginosa in the bowel can cause serious, some-
times fatal, infections. The major complications in 
our series were colonic perforation and sepsis. The 
severity of Pseudomonas enterocolitis reportedly 
ranges from a mild form that mimics ordinary gastro-
enteritis to more extensive disease, as was seen in 
our most seriously ill patients.5,7−9,12 In some studies, 
diarrhea has been reported as the initial manifes-
tation in more than 70% of patients with pseu-
domonal sepsis,6,7 so P. aeruginosa may need to be 
considered when evaluating patients with presumed 
infectious diarrhea.9,12 Alverdy et al used a mouse 
model of gut-derived sepsis caused by P. aeruginosa 
and found a dose-dependent effect; introduction 
of > 105 cfu/mL of the organism was more likely to 
cause severe sepsis and mortality.13 It is likely there-
fore that intestinal overgrowth of P. aeruginosa, 
normally present in the gut flora of 2% to 24% of 
individuals,7 precedes entry into the bloodstream. 
In our study, three patients developed sepsis; all 
of them had diarrhea before they had a high fever. 
There’s no way to tell if P. aeruginosa alone has 
caused an invasive GI infection leading to bacter-
emia or if other viral or bacterial gastroenteritis 
occurred first, resulting in breakdown of the normal 
intestinal mucosal barrier and allowing entry of 
P. aeruginosa.7 Our results are notable in that only 
infants in our series developed serious complications. 
Human neonates and infants have poor resistance to 
colonization by a variety of organisms because they 
have not yet developed a stable complex colonic 
microflora.14 This might allow for a heavier growth 
of P. aeruginosa than in older children and perhaps 
correspondingly larger inoculums if the organism 
invades the bowel wall and enters the bloodstream.
Skin lesions like ecthyma gangrenosum are com-
mon in Pseudomonas sepsis,4,7,8 but only one patient 
had a typical skin lesion in our study (Table 1). The 
pathophysiology of the skin lesion is a bacterial vas-
culitis.7,8 Most patients in our study had P. aeruginosa 
only in the GI tract but not bacteremia; this may 
explain the low incidence of skin lesion.
The risk factors in these infants were also eval-
uated. We found that an elevated band count or 
CRP level, anemia, and hypoalbuminemia may be 
the risk predictors. Some studies reported that 
patients with neutropenia had a higher mortality 
rate in pseudomonal sepsis. We also found that both 
of the expired infants in our study had neutropenia 
(ANC < 500/mm3). The severe complications in our 
patients were all noted within the first week after 
onset, unlike salmonellosis, in which complications 
are usually not seen until after the first week of 
illness.10,15 When enterocolitis follows an unusual 
course, especially in infants with an elevated band 
count or CRP level, anemia, or hypoalbuminemia, 
atypical causes such as Pseudomonas should be kept 
in mind, as early treatment with appropriate anti-
biotics may be life-saving.1,6
5. Conclusion
While pure growth of P. aeruginosa from the stool 
may be a transient phenomenon in healthy children, 
the organism can on occasion cause serious or even 
fatal complications. Such culture results should there-
fore not be overlooked in previously healthy children 
with an acute illness, particularly in infants with 
further cautions; bandemia (band form > 10% WBC) 
anemia (Hb ≤ 10 g/dL) and hypoalbuminemia (≤ 2.5 g/
dL). Due to the small numbers in this study, further 
large series evaluations should be undertaken.
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